8 companies hiring in Greater Philadelphia
8 companies hiring in Greater Philadelphia. (BioSpace.)
News Archive
Browse all past biotechnology intelligence, clinical developments, and industry updates.
Archived Updates
A $1B Acquisition Gives Novartis a Way to Stand Out in Crowded Area of Cancer
Myricx Bio brings to Novartis antibody drug conjugates with a novel cancer-killing payload called an NMT inhibitor. Novartis says Myricx’s drugs could have advantages over currently available ADCs as well as those still in clinical development.
A discarded Amgen T cell engager comes back to life at its California creator, 92Bio
A discarded Amgen T cell engager comes back to life at its California creator, 92Bio
A June flourish lifts biotech megaround tally in first half of 2026
A June flourish lifts biotech megaround tally in first half of 2026 — Endpoints News coverage of biopharma industry developments.
AbbVie and Genmab's latest win brings Epkinly closer to label expansion
AbbVie and Genmab's latest win brings Epkinly closer to label expansion — Endpoints News coverage of biopharma industry developments.
Backed by top VCs, biotech bags Alzheimer’s med in $2.2B deal
Backed by top VCs, biotech bags Alzheimer’s med in $2.2B deal — Fierce Biotech coverage of biopharma industry developments.
Biopharma strikes 50+ M&As deals in H1, led by Lilly’s $25B spend
Biopharma strikes 50+ M&As deals in H1, led by Lilly’s $25B spend. (BioSpace.)
Biotech startups are built on venture capital. Track funding rounds here.
Biotech startups are built on venture capital. Track funding rounds here. (BioPharma Dive.)
BridgeBio adds $1B as it prepares three more drug launches
BridgeBio adds $1B as it prepares three more drug launches
FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
FDA reviewers oppose allowing seven peptides for compounding
FDA reviewers oppose allowing seven peptides for compounding — Endpoints News coverage of biopharma industry developments.
FDA taps Lilly, Fujifilm and five more for its PreCheck pilot
FDA taps Lilly, Fujifilm and five more for its PreCheck pilot — Endpoints News coverage of biopharma industry developments.
Golden Triangle still dominates, but talent and capital gaps slow biotech growth
Golden Triangle still dominates, but talent and capital gaps slow biotech growth. (BioSpace.)
Haleon joins the AI deal wave with Microsoft collab
Haleon joins the AI deal wave with Microsoft collab. (Fierce Pharma.)
Hantavirus Is the Warning Signal America Should Not Ignore
Hantavirus Is the Warning Signal America Should Not Ignore — MedCity News coverage of biopharma industry developments.